Inhibrx Biosciences (INBX) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $8.9 million.
- Inhibrx Biosciences' Other Gross PP&E Adjustments fell 34.58% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year change of. This contributed to the annual value of $7.8 million for FY2024, which is 23.63% down from last year.
- Per Inhibrx Biosciences' latest filing, its Other Gross PP&E Adjustments stood at $8.9 million for Q3 2025, which was up 2.58% from $8.7 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Other Gross PP&E Adjustments ranged from a high of $13.6 million in Q3 2024 and a low of $7.8 million during Q4 2024.
- For the 3-year period, Inhibrx Biosciences' Other Gross PP&E Adjustments averaged around $10.0 million, with its median value being $8.9 million (2025).
- Data for Inhibrx Biosciences' Other Gross PP&E Adjustments shows a maximum YoY plummeted of 34.58% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Inhibrx Biosciences' Other Gross PP&E Adjustments stood at $10.2 million in 2023, then fell by 23.63% to $7.8 million in 2024, then plummeted by 34.58% to $8.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at $8.9 million for Q3 2025, versus $8.7 million for Q2 2025 and $8.2 million for Q1 2025.